To explore the effect of inhibiting S100a9 on myocardial fibrotic remodeling, we continuously administered intraperitoneal injections of the inhibitor for one week and assessed myocardial fibrosis levels in the mice. This evidence concerns the gene S100A9 and Myocardial fibrosis.